Bill
SF 4521
Hospital reimbursement for certain biological products to treat rare diseases provisions modifications
2025-2026 Regular Session
Introduced by Liz Boldon and 1 co-sponsor
SF 4521 modifies hospital reimbursement rules for rare disease biological products, affecting treatment access, costs, and healthcare provider financial sustainability in Minnesota.
Referred to Health and Human Services